Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system.
about
Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumptionNeurotrophins in the ventral tegmental area: Role in social stress, mood disorders and drug abuseRole of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axisRegulation of neuronal PLCgamma by chronic morphineExpression of brain-derived neurotrophic factors, neurotrophin-3, and neurotrophin-4 in the nucleus accumbens during heroin dependency and withdrawal.Increased opioid dependence in a mouse model of panic disorder.Role of BDNF and GDNF in drug reward and relapse: a reviewViral-mediated expression of extracellular signal-regulated kinase-2 in the ventral tegmental area modulates behavioral responses to cocaineThe role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity.BDNF is a negative modulator of morphine action.7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine.Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.Effect of chronic pain on fentanyl self-administration in mice.Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain ManagementEpigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental areaRole for GDNF in biochemical and behavioral adaptations to drugs of abuse.Brain-derived neurotrophic factor and neuropsychiatric disorders.BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot studyRegulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration.Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genesThe "ups and downs" of signaling cascades in addiction.GDNF and addiction.Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors.GDNF--a potential target to treat addiction.Characterizing intercellular signaling peptides in drug addictionPeripheral electrical stimulation reversed the cell size reduction and increased BDNF level in the ventral tegmental area in chronic morphine-treated rats.Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.Brain-derived neurotrophic factor and cocaine addiction.Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stressMultiple faces of BDNF in cocaine addiction.Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice.Transplantation of glial cell line-derived neurotrophic factor-expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self-administration in rats.Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawalProtein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal.The PKs PKA and ERK 1/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts.Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal.Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal.LTP in the mouse nucleus accumbens is developmentally regulated.Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN.
P2860
Q24530154-E55F027C-962C-400D-B3EB-8542584F94ECQ26991923-9D1DBBFE-B944-418A-A703-459FA8760E0DQ28484325-E5CF2B0F-91B3-4365-BD01-4D8412C9EE01Q28545272-5012C790-B082-4729-BB27-96C5DE87322BQ28575810-441D25E8-FD39-4443-96BE-188A9149ADCDQ30491763-FF053570-A591-4A59-9490-9954E7117553Q30493463-A3BF7D2F-272A-4A81-B8E7-0A5A623EDC71Q33939940-509B980C-1DF1-4A8E-9469-36A8940E2AB5Q34037180-4894EA16-C36E-4FB8-93EB-F0002FE73468Q34273723-10A41AB0-9BBF-42AE-AC34-35FCB5398202Q34304358-11196594-537C-493A-8DB7-04B248BC41B7Q34363249-F4D57C2E-6D38-4419-9C6B-D8FB367E1302Q34980182-D1EC66CC-3CB6-4EF9-BDA0-62BD46A6251BQ35048271-54C36FC4-BDB4-49AA-91C5-660BF6697D03Q35107834-FA8BF910-2ACF-496F-BF8C-C8EE456ED722Q35122229-0DC2D40D-063E-43B2-A789-256DF025E059Q35671426-78B799CA-6C5F-44F2-83E5-D22CF9EE429EQ35847085-FBAB38A8-21F6-4854-BE47-2A42D7E23C22Q35987786-E46BEE86-CDE0-4515-A577-098CB0D14B01Q36011875-B72F207B-430E-4FB2-A8EE-C53C847A3DEEQ36042505-17DB9DD8-4556-41F7-9806-2619D64F615FQ36309741-D511D714-6B1C-47E4-A55A-981D71BFE95AQ36414656-559EB5BD-20A0-4DBE-B4F0-21836D3355FEQ36914802-C719F696-74E6-42C9-9117-E566CED6433DQ36928841-26FF07C9-021D-417B-88ED-BC7FB5C408F2Q37149652-3FD3C0A9-1C15-4AE7-89B4-E61417DA8898Q37245071-52F21278-EF8D-4968-B148-405F6DA5637AQ37316191-22E50962-195B-4F88-AE3D-D0B879281423Q37592439-4F5E4A45-88FA-458D-AC7F-EFB22AF30EC2Q37719826-E3127CFA-DE1E-4CAC-A6D1-A77DF85BEF2CQ38275624-2C01E017-F3F4-4BE2-A2D0-88C579BC7B37Q40249567-A579DEC5-E755-4789-9AA0-90E08BFBAF31Q40616138-6FCB5191-528A-4DF3-AEE2-8DB09C81064AQ41591031-9AF2E2A9-A96E-4D4E-9CEF-3D6214304C09Q41774031-034AB1AC-7734-459D-8298-7C2653631365Q41813168-4839FA9B-548E-4BB6-83AA-270E39C8B4D0Q43263519-9BD34270-2844-4FA0-BA7D-B78CB3ECDD6EQ43632330-3F82B070-FC3A-45C1-A9B9-10C9113E5AA6Q44069085-18195FDC-4FB2-45DB-A95F-6CCC7C8990EFQ44282767-AC99FD42-160D-45DF-B6B9-2AAFA4FE9FE4
P2860
Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@en
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@nl
type
label
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@en
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@nl
prefLabel
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@en
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@nl
P2093
P1433
P1476
Influence of neurotrophic fact ...... he mesolimbic dopamine system.
@en
P2093
Beitner-Johnson D
Lindsay RM
Nestler EJ
Russell DS
Terwilliger RZ
P304
P356
10.1016/0306-4522(95)00207-Y
P407
P577
1995-10-01T00:00:00Z